Loss of taste and smell during treatment with topiramate

被引：10
作者：
Ghanizadeh, A. [1 ,2 ]
机构：
[1] Shiraz Univ Med Sci, Dept Psychiat, Res Ctr Psychiat Behav Sci, Hafez Hosp, Shiraz, Iran
[2] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Acad Child Psychiat Unit, Melbourne, Vic 3050, Australia
来源：
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY | 2009年 / 14卷 / 2-3期
关键词：
Topiramate; taste; smell; sensory; epilepsy; WEIGHT-GAIN; HALLUCINATIONS; EPILEPSY;
D O I：
10.1007/BF03327811
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Topiramate has already been suggested for treatment of olfactory hallucianation. This is a report of a three and a half-year-old boy with idiopathic generalized tonic colonic epilepsy. He had lost his ability to detect and recognize taste and odor during treatment with topiramate. Those abilities improved after discontinuation of topiramate. (Eating Weight Disord. 14: 037-038, 2009). (C) 2009, Editrice Kurtis
引用
收藏
页码：E137 / E138
页数：2
相关论文
共 8 条
  • [1] Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction
    Anghelescu, I
    Klawe, C
    Himmerich, H
    Szegedi, A
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (04) : 462 - 464
  • [2] Dursun SM, 2000, CAN J PSYCHIAT, V45, P198
  • [3] Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages
    Faught, E
    Wilder, BJ
    Ramsay, RE
    Reife, RA
    Kramer, LD
    Pledger, GW
    Karim, RM
    Barr, A
    Fischer, J
    Bergen, D
    Boor, D
    Browne, T
    Davenport, J
    Dichter, M
    Drake, M
    Kuzniecky, R
    Mamdani, M
    McCutchen, C
    Naritoku, D
    Potolicchio, S
    Ramani, V
    Ramsay, R
    Shinnar, S
    So, E
    Wilder, B
    [J]. NEUROLOGY, 1996, 46 (06) : 1684 - 1690
  • [4] Treatment of olfactory hallucinations with topiramate
    Johnson, Joel
    Bourgeois, James A.
    Quanbeck, Cameron
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (03) : 340 - 341
  • [5] Topiramate - A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy
    Langtry, HD
    Gillis, JC
    Davis, R
    [J]. DRUGS, 1997, 54 (05) : 752 - 773
  • [6] Use of topiramate for glossodynia
    Siniscalchi, Antonio
    Gallelli, Luca
    Marigliano, Norma Maria
    Orlando, Paola
    De Sarro, Giovambattista
    [J]. PAIN MEDICINE, 2007, 8 (06) : 531 - 534
  • [7] Topiramate treatment for SSRI-induced weight gain in anxiety disorders
    Van Ameringen, M
    Mancini, C
    Pipe, B
    Campbell, M
    Oakman, J
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 981 - 984
  • [8] Wu W. N., 1994, Pharmaceutical Research (New York), V11, pS336
1